Michael A. Tortorici, Theresa Yuraszeck, David Cornblath, Vera Bril, Hans‐Peter Hartung, Gen Sobue, . . . the PATH study group. (2021). Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy. Wiley.
Chicago Style (17th ed.) CitationMichael A. Tortorici, et al. Pharmacometric Analysis Linking Immunoglobulin Exposure to Clinical Efficacy Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy. Wiley, 2021.
MLA (9th ed.) CitationMichael A. Tortorici, et al. Pharmacometric Analysis Linking Immunoglobulin Exposure to Clinical Efficacy Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy. Wiley, 2021.
Warning: These citations may not always be 100% accurate.